Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
The Robotics Boom: How Chang Robotics Is Rebuilding American Manufacturing
Chang Robotics CEO Matt Chang discusses physical AI, automated factories and the push to reshore critical manufacturing to the U.S.
The 2030 Deadline: Why NYC's Buildings Are Racing the Climate Clock
NYC's buildings are on the climate clock. Urban Green Council breaks down lobby letter grades, Local Law 97, smart tech and the city's race to net zero.
The Job Market’s Next Chapter: Where Workers Are Still in Demand
Kory Kantenga, Head of Economics, Americas at LinkedIn, breaks down hiring trends, labor-market resilience and where employers are still seeking workers.
AI Investing Takes Off: Why Younger Investors Are Turning to AI for Research
Bret Kenwell, U.S. Investment and Options Analyst at eToro, breaks down how younger investors are using AI and where they’re looking beyond Big Tech.
Why Americans Are Spending More on Hobbies Despite Economic Pressure
Joe Wadford, Economist at Bank of America, breaks down the hobby spending boom, “funflation” and why millennials and Gen Z spend differently.
Vanessa Hudgens’ Next Big Role? Building a Cactus Water Brand
Vanessa Hudgens and Oliver Trevena, co-founders of Caliwater, reveal why they’re betting on cactus water, the rise of healthy beverages and plans to grow bigger
